News

Photo

Boehringer Ingelheim Expands Cancer Research at Vienna Site

On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to Boehringer Ingelheim, the investment of around €60 million is further proof of the company's commitment to cancer research.

Photo

ECI Group Secures First 150kta Copolymer License

ECI Group recently announced the signing of a licensing agreement with Shaanxi Yanchang China Coal Yulin Energy & Chemical Co., Ltd. (YECC) to deliver a 150kta copolymer plant project using ECI Group’s proprietary hybrid reactor technology.

Photo

Lonza Launches Innovaform Accelerator

Lonza inaugurated its new facility at the Colmar, France site. The new Innovaform Accelerator will serve as a Center of Excellence for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.

Photo

Ucaneo Secures Seed Funding

Ucaneo, a provider of innovative direct air capture (DAC) technologies for CO2 removal, has raised €6.75 million in seed funding including grants.

Photo

Egrobots – New Technologies for a more Sustainable Agriculture

Egrobots, a start-up from Egypt, developed a solution for efficient farm monitoring and management using AI and robotics. Their innovation includes an autonomous robot, that roams around the farm, scanning the plants on a leaf-level with high resolution and an AI that analyses this data.

Photo

Nouryon Begins Operations in Mato Grosso do Sul, Brazil

Nouryon recently announced it has commenced operations at its new Integrated Manufacturing Model site in Ribas do Rio Pardo, Mato Grosso do Sul, Brazil, which includes the production of hydrogen peroxide, sodium chlorate, and chlorine dioxide.

Photo

Flow Chemistry in Drug Discovery

For the synthesis of compounds in pharmaceutical applications, it is important to select the most appropriate flow chemistry regime and equipment based on the goals of the application.

Photo

Minicircle DNA

The minicircle has emerged as a Next Generation Gene Vector and as a promising tool in the field of gene delivery and therapeutic applications. This overview aims to cover the characteristics, production methods, and potential applications of minicircle DNA.

Photo

Europe’s Biotech Cluster Powerhouses

Cambridge, Leiden, Heidelberg or Paris - many European countries have biotechnology clusters in which scientific expertise meets a well-developed infrastructure, committed entrepreneurship and attractive financing opportunities. A subjective look at the best.

Photo

The CDMO/CMO Report

Driven by increased demand in biologic-based drugs, biologic drug substance manufacturing continues to be an active area of investment by contract development and manufacturing organizations/contract manufacturing organizations (CDMOs/CMOs), including several multi-billion large-scale biomanufacturing projects. What companies are expanding, and where do these expansions stand?

Photo

Pharma’s Digital Transformation

Industry experts Michelangelo Canzoneri, Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 guide core team – explain the transformational challenges and critical success factors of the digital Pharma 4.0 journey.

Photo

Chemical Logistics Study 2024

A study on logistics in the chemical industry shows that there is a significant need to develop a more professional approach to supply chain and logistics planning and the use of digitalization and AI, but that the industry is currently struggling with limited resources and budget constraints.

Photo

Serán More Than Doubles Clinical Manufacturing Capacity

CDMO Serán BioScience recently announced that it has completed an expansion to increase the number of process manufacturing suites at its facility in Bend, Oregon, from 6 to 14, adding approximately 130% more cGMP clinical manufacturing capacity.

Photo

​​Lonza Completes Expansion of Microbial Manufacturing Facility

Lonza recently announced that it has completed a planned expansion of the mid-scale microbial manufacturing facility at its Visp, Switzerland site. This multi-product facility was recently granted a GMP license, allowing cGMP manufacturing and release of biologics produced using microbial fermentation.

Photo

Medera to Go Public through Merger with KVAC

Keen Vision Acquisition Corp. (KVAC) and Medera, a clinical-stage biotechnology company, have entered into a merger agreement. Upon closing of the merger, which is expected to occur in the fourth quarter of 2024, the combined company will operate under the name Medera.

Photo

LanzaTech, Seksui to Develop Waste-to-Ethanol Plants in Japan

US green technology firm LanzaTech has signed an agreement with Sekisui Chemical to deploy, at commercial scale, a jointly developed platform that converts syngas derived from municipal solid waste (MSW) and industrial solid waste into ethanol. Sekisui intends to build multiple facilities in municipalities across Japan which incorporate equipment packages, engineering and advisory services, consumables, and intellectual property provided by LanzaTech, the companies said.

Photo

Olon Acquires Huvepharma Italia

Olon continues its growth path and increases its total production capacity following the acquisition of Huvepharma Italia and its site in Garessio, Cuneo, in the northwestern part of Italy.

Photo

QatarEnergy to Build Urea Complex at Mesaieed

QatarEnergy has decided to build a new, world-scale urea production complex in Mesaieed Industrial City. The project comprises the construction of three ammonia production lines that will supply feedstock to four new urea production trains at the site.

Photo

UCB to Sell Neurology and Allergy Business in China

Belgium-headquartered biopharmaceutical company UCB is to sell its mature neurology and allergy business in China to Singapore-based asset management group CBC and investor Mubadala, based in Abu Dhabi, for $680 million.

13331 more News

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.